Continuum Advisory’s Alkermes ALKS Stock Holding History

Continuum Advisory’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-78	Closed	-$1.88K	–	1916
2024 Q2	$1.88K	Hold	78	–	–	﹤0.01%	1317
2024 Q1	$1.89K	Buy	+78	New	+$2.21K	﹤0.01%	1317

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Continuum Advisory's ALKS Position: Q3 2024 in Review

Continuum Advisory sold out of Alkermes (ALKS) in Q3 2024, closing a stake of 78 shares — an estimated $1.88K sold.

Continuum Advisory first reported a position in ALKS in Q1 2024 and held it in 2 quarters. The position peaked at $1.89K in Q1 2024. 338 funds tracked by Wall St. Rank hold ALKS as of Q3 2024.

Continuum Advisory reported no remaining Alkermes position as of Q3 2024 after selling out during the quarter.
Continuum Advisory sold 78 Alkermes shares in Q3 2024, an estimated $1.88K.
Continuum Advisory first reported a position in Alkermes in Q1 2024 and held it in 2 quarters.
Continuum Advisory's Alkermes position peaked at $1.89K in Q1 2024.
338 funds tracked by Wall St. Rank held Alkermes as of Q3 2024.

Based on Continuum Advisory's 13F filing for Q3 2024, filed 15 Nov 2024.